← Back to Patent Explorer
US4388308A Expired / Lapsed US ⏱️ 0.0 years remaining

N6 -[(2-Hydroxypropyl)aryl]adenosines

Assignee: GDSEARLE & Co A CORP OF DE
•
Filing: 1980-06-09
•
Granted: 1983-06-14
•
Expires: 2000-06-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract N 6 -2-hydroxypropylaryl-substituted adenosines and adenines represented by the formula ##STR1## wherein R 1 is selected from the group consisting of naphthyl, phenyl, substituted phenyl or biphenyl; and R 2 is hydrogen or 1-β-ribosyl; and the pharmaceutically acceptable salts thereof. The compounds are anti-hypertensive agents.

Inventors

  • 👤 Robert W. Hamilton
  • 👤 Richard E. L. Henderson
  • 👤 Barnett S. Pitzele

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 12:57
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; A; A61; A61P; A61P9/00; A61P9/12; C07D; C07D473/00; C07D473/26; C07D473/32; C07D473/34

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 32 words
An N 6 -substituted adenosine represented by the formula: ##STR5## wherein R 1 is selected from the group consisting of naphthyl, acetylphenyl, 2-propenylphenyl and 1, 2-biphenyl; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 32 words
An N 6 -substituted adenosine represented by the formula: ##STR5## wherein R 1 is selected from the group consisting of naphthyl, acetylphenyl, 2-propenylphenyl and 1, 2-biphenyl; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 28 words
A pharmaceutical composition which is useful in treating a hypertensive patient composing an effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier or diluent.
Claim 4
Dependent Claim 18 words
A pharmaceutical composition of claim 1, which is useful in treating a hypertensive patient suitable for oral administration.
Claim 5
Dependent Claim 26 words
A method of reducing blood pressure in a hypertensive mammalian patient comprising administering a therapeutically effective dose of a compound of claim 1 to said patient.
Claim 6
Dependent Claim 11 words
The method of claim 4 wherein said compound is administered orally.
Claim 7
Dependent Claim 9 words
A compound of claim 1: N 6 -{2-hydroxy-3-[(2-propenyl)phenoxy]propyl} adenosine.
Claim 8
Dependent Claim 9 words
A compound of claim 1: N 6 -[3-(3-acetylphenoxy)-2-hydroxypropyl] adenosine.
Claim 9
Dependent Claim 9 words
A compound of claim 1: N 6 -[3-(4-acetylphenoxy)-2-hydroxypropyl] adenosine.
Claim 10
Dependent Claim 9 words
A compound of claim 1: N 6 -[2-hydroxy-3-(1-Naphthalenyloxy)propyl] adenosine.
Claim 11
Dependent Claim 9 words
A compound of claim 1: N 6 -{3-[1,1'-biphenyl)-2-yloxy]-2-hydroxypropyl} adenosine.
Claim 12
Dependent Claim 22 words
A pharmaceutical composition of claim 2, which is useful in treating a hypertensive patient, wherein said compound is: N 6 -{2-hydroxy-3-[(2-propenyl)phenoxy] propyl}adenosine.
Claim 13
Dependent Claim 22 words
A pharmaceutical composition of claim 2, which is useful in treating a hypertensive patient, wherein said compound is: N 6 -[3-(3-acetylphenoxy-2-hydroxypropyl] adenosine.
Claim 14
Dependent Claim 22 words
A pharmaceutical composition of claim 2, which is useful in treating a hypertensive patient, wherein said compound is: N 6 -[3-(4-acetylphenoxy)-2-hydroxypropyl] adenosine.
Claim 15
Dependent Claim 22 words
A pharmaceutical composition of claim 2 which is useful in treating a hypertensive patient, wherein said compound is: N 6 -[2-hydroxy-3-(1-naphthalenyloxy)propyl] adenosine.
Claim 16
Dependent Claim 22 words
A pharmaceutical composition of claim 2, which is useful in treating a hypertensive patient, wherein said compound is: N 6 -{3-[(1,1'-biphenyl)-2-yloxy]-2-hydroxypropyl} adenosine.

References Cited (Backward Citations)

US3929763A Cited
US4138562A Cited
US4221910A Cited
US4309419A Cited
US4340730A Cited
US4315000A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-06-13 1986-12-13 1987-06-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-06-13 1990-12-13 1991-06-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-06-13 1994-12-13 1995-06-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag